Showing results (221-230 of 413) with videos related to

Sort By:
Pageof 42
JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
Oncotarget|June 19, 2023
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancerDevalingam Mahalingam, Salih Hanni, Anthony V Serritella, et al.
The Journal of Urology|August 18, 2009
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosisJoke Beuten, Dawn Garcia, Timothy C Brand, et al.
The Journal of Urology|May 28, 2013
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO GuidelineIan M Thompson, Richard K Valicenti, Peter Albertsen, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
The Journal of Urology|October 20, 2009
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detectionStephen J Eyre, Donna P Ankerst, John T Wei, et al.
Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.
The Journal of Urology|April 20, 2013
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-GuérinEila C Skinner, Bryan Goldman, Wael A Sakr, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2025
Emerging Strategies for Drug-Based Cancer Risk ReductionMaria Daca-Álvarez, Angelo Brunori, Alessio Carbone, et al.
Pageof 42